Addressing gaps in pharmacovigilance practices in the antiretroviral therapy program in the Eastern Cape Province, South Africa

Research in Social and Administrative Pharmacy

Volumn 6, Issue 4, 2010, Pages 345-353

  Ruud, Karine Wabø ^a   Srinivas, Sunitha C ^b   Toverud, Else Lydia ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b RHODES UNIVERSITY   (South Africa)

Author keywords

Antiretroviral treatment; HIV AIDS; Pharmacovigilance; Primary health care

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; SOUTH AFRICA; STANDARD;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-HIV AGENTS; FEMALE; FOCUS GROUPS; HEALTH PERSONNEL; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; QUALITY OF HEALTH CARE; SOUTH AFRICA; YOUNG ADULT;

EID: 78649471060     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2009.11.006     Document Type: Article

References (25)

1. UNAIDS, WHO AIDS Epidemic Update December 2007 2007, UNAIDS, WHO, Geneva, Switzerland.
2. Benatar S.R. Health care reform and the crisis of HIV and AIDS in South Africa. N Engl J Med 2004, 351(1):81-92.
3. Hall E.J. Nursing attrition and the work environment in South African health facilities. Curationis 2004, 27(4):28-36.
4. Grubb I., Perriëns J, Schwartländer B. A Public Health Approach to Antiretroviral Treatment: Overcoming Constraints 2003, World Health Organization, Geneva, Switzerland.
5. Mehta U., Durrheim D.N., Blockman M, Kredo T, Gounden R, Barnes K.I. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol 2007, 65(3):396-406.
6. Katende-Kyenda N.L., Lubbe M.S., Serfontein J.H., Truter I. Prevalence of drug-drug interactions of antiretroviral agents in the private health care sector in South Africa. S Afr Med J 2008, 98(2):109-113.
7. WHO. Pharmacovigilance for antiretrovirals in resource-poor countries. Geneva, Switzerland: WHO 2007.
8. Hughes M.L., Whittlesea C.M., Luscombe D.K. Review of national spontaneous reporting schemes. Strengths and weaknesses. Adverse Drug React Toxicol Rev 2002, 21(4):231-241.
9. Fomundam H, Meyers G, Kayongo D. Models of care project (HIV/AIDS treatment programme). Pharmacovigilance plan and training, Grahamstown Settlers hospital: Eastern Cape Regional Training Centre (ECRTC); 2007.
10. Bäckström M., Mjörndal T., Dahlqvist R. Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepidemiol Drug Saf 2002, 11(8):647-650.
11. Lopez-Gonzalez E., Herdeiro M.T., Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 2009, 32(1):19-31.
12. Eland I.A., Belton K.J., van Grootheest A.C., Meiners A.P., Rawlins M.D., Stricker B.H. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 1999, 48(4):623-627.
13. Hasford J., Goettler M., Munter K.H., Müller-Oerlinghausen B. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol 2002, 55(9):945-950.
14. Okezie E.O., Olufunmilayo F. Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf 2008, 17(5):517-522.
15. Khoza S., Madungwe I., Nyambayo P., Mthethwa J., Chikuni O. Adverse drug reactions reporting at a referral hospital in Zimbabwe. Cent Afr J Med 2004, 50(11-12):104-107.
16. Ekbom Y., Hedenmalm K., Dalin L., Lönnroth K., Persson I. Reporting of side-effects-a system in need of improvement. Reporting of a physician questionnaire. Lakartidningen 2002, 99(34):3290-3295.
17. Roberts K.J. Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care STDS 2000, 14(3):155-168.
18. Weiser S., Wolfe W., Bangsberg D., et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr 2003, 34(3):281-288.
19. Chesney M. Adherence to HAART regimens. AIDS Patient Care STDS 2003, 17(4):169-177.
20. Li Q., Zhang S.M., Chen H.T., et al. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J (Engl) 2004, 117(6):856-861.
21. HST South African Health Review 2008 2008, Health Systems Trust, Durban, South Africa.
22. Oshikoya K.A., Awobusuyi J.O. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol 2009, 9(14).
23. Pedrós C., Vallano A., Cereza G., et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf 2009, 32(1):77-83.
24. Adverse Drug Reaction and Medicine Review Committee Evaluation of a training course on pharmacovigilance in sub-Saharan Africa. Pharmacoepidemiol Drug Saf 2000, 9(2):133-138.
25. Sevene E., Mariano A., Metha U., et al. Spontaneous adverse drug reaction reporting in rural districts of Mozambique. Drug Saf 2008, 31(10):867-876.